CPIX

CPIX Cumberland Pharmaceuticals Inc.

Stock · NasdaqGS · United States · Healthcare · US2307701092

NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Cumberland Pharmaceuticals Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price 5.22 USD +4.19%

52-week range 1.85 – 9.28

Dividend yield—

Market cap78.2M

NowoTrade score 5 Grade B

Price history

Daily prices in USD.

Updated 08 Nov 2026 14:52. Information, not advice.

Results

Next results 10 Nov 2026 in 2 days · 16:00

Last results 0.07 vs -0.07 estimated 11 May 2021 · Beat +200.0%

Beat the estimate 10 of 12 2 missed · 0 in line · 4 beats in a row

Average surprise +162.2% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
10 Nov 2026 16:00	—	—	—	Upcoming
10 Aug 2021 16:00	-0.07	—	+98.4%	—
11 May 2021 16:00	-0.07	0.07	+200.0%	Beat
09 Mar 2021 16:00	-0.01	0.01	+200.0%	Beat
10 Nov 2020 16:00	-0.07	0.02	+128.6%	Beat
11 Aug 2020 16:00	0.03	0.08	+166.7%	Beat
20 May 2020 16:00	0.02	0.01	-50.0%	Miss
18 Mar 2020 16:00	0.01	0.09	+800.0%	Beat
12 Nov 2019 16:00	0.11	0.01	-90.9%	Miss
14 Aug 2019 16:00	0.07	0.10	+42.9%	Beat
14 May 2019 16:00	-0.11	0.11	+200.0%	Beat
26 Feb 2019 16:00	-0.16	0.10	+162.5%	Beat
13 Nov 2018 16:00	-0.19	-0.05	+73.7%	Beat
14 Aug 2018 16:00	-0.08	0.01	+112.5%	Beat
08 May 2018 16:00	-0.02	-0.09	-350.0%	Miss
06 Aug 2013 16:00	0.02	-0.03	-266.5%	Miss
02 May 2013 16:00	0.05	0.05	+9.1%	Beat
28 Feb 2013 16:00	0.14	0.12	-12.2%	Miss
01 Nov 2012 16:00	0.09	0.10	+16.9%	Beat
02 Aug 2012 16:00	0.07	0.09	+37.9%	Beat
03 May 2012 16:00	0.05	0.02	-61.1%	Miss
29 Feb 2012 16:00	0.05	0.04	-11.2%	Miss
03 Nov 2011 16:00	0.06	0.09	+48.3%	Beat
04 Aug 2011 16:00	0.04	0.11	+193.3%	Beat
04 May 2011 16:00	0.03	0.03	+3.1%	Beat
08 Mar 2011 16:00	0.03	0.04	+30.4%	Beat
11 Nov 2010 16:00	0.01	0.05	+261.3%	Beat
16 Aug 2010 16:00	0.04	0.01	-73.5%	Miss
15 Aug 2010 20:00	0.02	0.02	0.0%	In line
13 May 2010 16:00	0.02	0.02	0.0%	In line
10 Mar 2010 08:00	0.01	0.01	+11.7%	Beat
10 Nov 2009 12:00	0.03	0.10	+200.0%	Beat

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	44.5M	+17.6%	-2.8M	-6.4%	-0.19	+58.7%	4.8M
2024	37.9M	-4.3%	-6.5M	-17.1%	-0.46	-4.5%	-791.9K
2023	39.6M	-5.9%	-6.3M	-15.9%	-0.44	-15.8%	5.6M
2022	42M	—	-5.6M	-13.3%	-0.38	—	6.4M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by day
Period	Opening price	High	Low	Closing price	Change	Volume
07 Apr 2022	2.77	3.10	2.70	3.03	+9.39%	109,200
06 Apr 2022	2.65	2.80	2.63	2.77	+3.75%	33,300
05 Apr 2022	2.79	2.96	2.63	2.67	-6.32%	30,600
04 Apr 2022	2.92	2.94	2.81	2.85	-2.40%	26,400
01 Apr 2022	2.86	3.00	2.72	2.92	+3.55%	111,500
31 Mar 2022	2.89	3.15	2.60	2.82	+8.46%	548,600
30 Mar 2022	2.66	2.83	2.60	2.60	-5.11%	24,700
29 Mar 2022	2.58	2.76	2.58	2.74	+3.40%	31,000
28 Mar 2022	2.86	2.86	2.56	2.65	-3.99%	19,700
25 Mar 2022	2.85	2.91	2.76	2.76	-2.13%	27,600
24 Mar 2022	2.78	2.88	2.76	2.82	+1.08%	21,100
23 Mar 2022	2.71	2.88	2.63	2.79	+2.57%	15,100
22 Mar 2022	2.74	2.85	2.66	2.72	-1.45%	16,700
21 Mar 2022	2.68	2.89	2.68	2.76	+0.36%	15,000
18 Mar 2022	2.74	2.86	2.65	2.75	+0.36%	16,000
17 Mar 2022	2.64	2.74	2.64	2.74	+5.79%	31,600
16 Mar 2022	2.58	2.73	2.58	2.59	+1.17%	14,400
15 Mar 2022	2.62	2.69	2.55	2.56	-0.39%	24,800
14 Mar 2022	2.70	2.84	2.57	2.57	-4.46%	31,900
11 Mar 2022	2.94	3.00	2.66	2.69	-9.43%	75,100
10 Mar 2022	2.60	2.99	2.60	2.97	+8.39%	28,000
09 Mar 2022	2.75	3.02	2.43	2.74	+0.37%	159,100
08 Mar 2022	2.96	3.17	2.73	2.73	-8.08%	67,500
07 Mar 2022	3.07	3.17	2.92	2.97	-6.01%	32,800
04 Mar 2022	3.09	3.22	3.08	3.16	+0.64%	29,000

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q3 2026 FINANCIAL RESULTS (opens in a new tab) 03 Nov 2026 21:05
Cumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne Cardiomyopathy (opens in a new tab) MarketBeat · 26 Oct 2026 22:02
Cumberland Pharmaceuticals stock tumbles on trial results (opens in a new tab) Investing.com · 23 Oct 2026 22:08

Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 5.01 USD
Market cap: 78.2M
Last dividend: 1.5000 USD · 03 Aug 2026
Exchange: NasdaqGS
Country: United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Currency: USD

Dividends

Ex-dividend date	Per share
03 Aug 2026	1.5000 USD

Why this score

How the score is made up
Part of the score	Points	Why
Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble.	3.8 / 25	Yield of 28.7% on today's price (very high: check why)
Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover.	8.3 / 25	Dividend uses 0% of earnings
Dividend growth How many years in a row the dividend has risen, and how fast.	5.2 / 15 No figures for this part: it counts as a cautious 35%.	—
Quality Return on equity, net margin and how stable the margins are.	1.8 / 15	ROE of -14%
Valuation Free cash flow yield and the P/E against its sector.	0.0 / 10	—
Analysts How far the analysts' average target is from today's price.	1.8 / 5 No figures for this part: it counts as a cautious 35%.	—

Score capped at 50: a yield of 29% is more often a warning than a prize
Thin interest cover: operating profit is only -5.6× the interest
The last full year was a loss
The price is 42% below its 52-week high: check why before relying on the yield

Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 75% of the figures (grade B). Warnings take 18 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.

Figures

Valuation
Figure	Value	Reading	Sector median
P/E (forward)	37.29×	Weak	14.89×
Price / book	4.48×	Weak	3.81×
Price / sales	1.77×	Good	3.19×
EV / EBITDA	71.79×	Weak	12.63×
Free cash flow yield	-0.2%	Weak	2.5%

Quality
Figure	Value	Reading	Sector median
Gross margin	85%	Good	58.6%
Operating margin	-1,898.7%	Weak	7.8%
Net margin	-24.6%	Weak	2.8%
Return on equity	-14.4%	Weak	5.7%
Return on assets	-2.9%	Weak	3.6%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	2%	Weak	10.8%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	0.28×	Good	0.48×
Net debt / EBITDA	0.78×	Good	1.6×
Interest cover	-5.63×	Weak	2.69×
Current ratio	0.96×	Weak	2.39×

Dividends
Figure	Value	Reading	Sector median
Payout of earnings	0%	Weak	0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Follow CPIX and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in